ArticleTranslational lung cancer research2022

Osimertinib as induction therapy for oligometastatic non-small cell lung cancer with EGFR mutation: a case report.

Han Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.